ArticleOncology reports2018

MicroRNA‑424 serves an anti‑oncogenic role by targeting cyclin‑dependent kinase 1 in breast cancer cells.

Dan Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.